Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHiscox Regulatory News (HSX)

Share Price Information for Hiscox (HSX)

Share Price is delayed by 15 minutes
Get Live Data
1,727.00    -27.00 (-1.54%)
Bid:
1,727.00
Ask:
1,728.00
Spread: 1.00 (0.058%)
Market Cap: £5.54b
HSX Live PriceLast checked at - London Stock Exchange

Intraday Hiscox Share Chart

Share Repurchase Programme.

3 May 2024 07:01

RNS Number : 0878N
Hiscox Ltd
03 May 2024
Β 

Β 

Update on share repurchase programme

Β 

Hamilton, Bermuda (3 May 2024) - Hiscox Ltd ("Hiscox" or the "Company") today announces that, further to the share repurchase programme announced on 5 March 2024 to buy back its ordinary shares of 6.5 pence each ("Ordinary Shares") for a maximum aggregate consideration of $150 million (the "Programme"), the Company completed the initial tranche of the Programme on 2 May 2024. The Company purchased 4,896,100 Ordinary Shares between 5 March 2024 and 2 May 2024 pursuant to the agreement with Peel Hunt LLP to conduct the initial tranche of the programme totalling $75 million (excluding expenses).

Β 

Having completed the initial tranche, Hiscox has entered into an agreement with Citigroup Global Markets Limited ("Citigroup") to conduct the second tranche of the Programme, commencing today and ending no later than the end of the third quarter of 2024, for a maximum aggregate consideration of $75 million with the Company subsequently purchasing its Ordinary Shares from Citigroup. Under this arrangement, Citigroup will act as principal.

Β 

Purchases under the Programme will take place in open market transactions and may be made from time to time by Citigroup, depending on market conditions, share price and trading volumes. The Programme is effected under the authority granted by shareholders at the Company's 2023 Annual General Meeting held on 11 May 2023 (and any subsequent authority), the maximum number of shares that may be repurchased under the Programme is 34,655,073 Ordinary Shares. Following the completion of tranche one, 29,758,973 Ordinary Shares can be purchased under the second tranche of the Programme. Any purchases contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s).

Β 

The Programme will end when the maximum aggregate consideration under the second tranche reaches $75 million or as otherwise terminated.

Β 

The Programme will continue to be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 as it forms part of UK law pursuant to the UK's European Union (Withdrawal) Act 2018 and the Market Abuse (Amendment) (EU Exit) Regulations 2019) as well as applicable laws and the regulations of the UK Financial Conduct Authority (including Chapter 12 of the Listing Rules).

Β 

The purpose of the Programme is to reduce the issued share capital of the Company. The purchased Ordinary Shares will be cancelled.

Β 

Any repurchase of shares will be announced no later than 7:30 a.m. on the business day following the calendar day on which the repurchase occurred.

Β 

There is no guarantee that the Programme will be implemented in full.

Β 

ENDS

Β 

Β 

For further information

Investors and analysts

Yana O'Sullivan, Director of Investor Relations, London +44 (0)20 3321 5598

Marc Wetherhill, Group Company Secretary, Bermuda +1 441 278 8300

Β 

Media

Eleanor Orebi Gann, Group Director of Communications, London +44 (0)20 7081 4815

Simone Selzer, Brunswick +44 (0)20 7404 5959

Tom Burns, Brunswick +44 (0)20 7404 5959

Notes to editors

About The Hiscox Group

Hiscox is a global specialist insurer, headquartered inΒ BermudaΒ and listed on the London Stock Exchange (LSE:HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle.Β 

The Hiscox Group employs over 3,000 people in 14 countries, and has customers worldwide. Through the retail businesses in the USA, UK, Europe and Asia, we offer a range of specialist insurance products in commercial and personal lines. Internationally-traded, bigger-ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS.

Our values define our business, with a focus on people, courage, ownership and integrity.Β We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
POSZZGGKRZVGDZM
Date   Source Headline
6th Nov 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
2nd Nov 20207:00 amRNSHiscox Ltd trading statement
12th Oct 202011:22 amRNSTR-1: Standard form-notification of major holdings
1st Oct 202011:48 amRNSTotal Voting Rights
1st Oct 202011:40 amRNSDirector/PDMR Shareholding
29th Sep 20207:13 amRNSUpdate on UK Insurance Industry Test Case
16th Sep 202011:54 amRNSNotification of transactions by PDMR
15th Sep 202011:25 amRNSResponse to Insurance Industry Test Case Judgment
14th Sep 20204:35 pmRNS2021 Syndicate Business Forecast
7th Aug 20207:00 amRNSCorrection: Syndicate results and estimates
3rd Aug 20207:01 amRNSHiscox Ltd interim results
3rd Aug 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
22nd Jun 20205:27 pmRNSTR-1: Standard form-notification of major holdings
19th Jun 202012:19 pmRNSRights Attaching to Equity Shares
9th Jun 20204:27 pmRNSTR-1: Standard form-notification of major holdings
3rd Jun 202012:03 pmRNSTR-1: Standard form-notification of major holdings
1st Jun 20201:27 pmRNSTotal Voting Rights
1st Jun 20207:35 amRNSHiscox Ltd response to FCA announcement
28th May 20203:23 pmRNSTR-1: Standard form-notification of major holdings
20th May 20204:21 pmRNSTR-1: Standard form-notification of major holdings
20th May 202012:03 pmRNSDirector / PDMR Shareholding
19th May 202012:09 pmRNSDirector Declaration
18th May 20202:58 pmRNSTR-1: Standard form-notification of major holdings
15th May 20207:00 amRNSAGM Results
14th May 20202:06 pmRNSDirector/PDMR Shareholding
13th May 20204:20 pmRNSTR-1: Standard form-notification of major holdings
13th May 20208:53 amRNSTR-1: Standard form-notification of major holdings
11th May 20202:40 pmRNSTR-1: Standard form-notification of major holdings
6th May 20205:30 pmRNSHiscox
6th May 20207:00 amRNSResults of capital raise
5th May 20204:35 pmRNSProposed capital raise of ordinary shares
5th May 20204:35 pmRNSHiscox Ltd trading statement
4th May 20207:00 amRNSSyndicates 33 and 6104 – results and estimates
1st May 202012:29 pmRNSTotal Voting Rights
29th Apr 20207:00 amRNSResponse to press speculation
22nd Apr 20207:00 amRNSMarket update on COVID-19 exposure
15th Apr 20202:20 pmRNSMarket update re business interruption exposure
14th Apr 20202:38 pmRNSNotice of 2020 Annual General Meeting
8th Apr 20207:00 amRNSUpdate on dividend payment and guidance
1st Apr 202012:07 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20201:08 pmRNSDirector/PDMR Shareholding
11th Mar 20202:36 pmRNSAnnual Report
5th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20203:38 pmRNSChief Underwriting Officer
2nd Mar 202012:50 pmRNSSyndicates 33 and 6104 – results and estimates
2nd Mar 20207:01 amRNSHiscox Ltd full year results
6th Jan 202010:06 amRNSTR-1: Standard form-notification of major holdings
2nd Jan 20201:13 pmRNSTotal Voting Rights
17th Dec 20192:33 pmRNSNotification of transactions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.